Filter
2240
Filtered Results: 2240
Text search:
drug
distribution
centers
Featured
Recommendations
176
New Publications
696
Language
Document type
No document type
1464
Studies & Reports
339
Guidelines
246
Manuals
75
Strategic & Response Plan
58
Training Material
23
Situation Updates
18
Fact sheets
11
Infographics
4
Brochures
1
Resource Platforms
1
Countries / Regions
India
119
Ethiopia
78
Kenya
64
Liberia
58
Uganda
55
Nepal
46
Global
46
Nigeria
44
Tanzania
42
Rwanda
41
Latin America and the Carribbean
41
Sierra Leone
37
Zambia
37
Malawi
34
Bangladesh
32
Western and Central Europe
30
Myanmar / Burma
28
Philippines
27
Cambodia
27
South Africa
27
Namibia
27
Ghana
26
Africa
24
Ukraine
23
Lesotho
18
Zimbabwe
18
Mozambique
18
Senegal
17
South–East Asia Region
16
Eastern Europe
16
Asia
14
Indonesia
14
Russia
13
Burkina Faso
12
Congo, Democratic Republic of
12
Botswana
12
Colombia
10
USA
10
Haiti
10
Brazil
10
Syria
9
Albania
8
East and Southern Africa
8
Tajikistan
7
Thailand
6
Cameroon
6
Guinea
6
Venezuela
6
Middle East and North Africa
6
Germany
5
Georgia
5
South Sudan
5
Pakistan
5
Afghanistan
4
Armenia
4
West and Central Africa
4
Paraguay
4
Argentina
4
Vietnam
4
Eswatini/ Swaziland
4
Turkey
3
Peru
3
Eastern Europe and Central Asia
3
Spain
3
Moldova
3
Iraq
3
North Macedonia
2
Chile
2
Laos
2
Jordan
2
Western Pacific Region
2
North America
2
Gabon
2
Bolivia
2
Sudan
2
Yemen
2
Angola
2
Timor Leste/ East Timor
1
El Salvador
1
Benin
1
China
1
Kazakhstan
1
Iran
1
Canada
1
Fiji
1
Estonia
1
Kyrgyzstan
1
Mongolia
1
Guinea-Bissau
1
Turkmenistan
1
France
1
United Kingdom
1
Portugal
1
Côte d’Ivoire / Ivory Coast
1
Sri Lanka
1
Romania
1
Palestine
1
Central African Republic
1
Chad
1
Bhutan
1
Ecuador
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
947
Clinical Guidelines
191
Public Health
114
Women & Child Health
73
Key Resources
40
Capacity Building
29
Pharmacy & Technologies
26
Annual Report MEDBOX
1
Toolboxes
HIV
272
TB
193
Mental Health
184
AMR
120
COVID-19
87
NTDs
85
Pharmacy
57
Rapid Response
46
Caregiver
36
Planetary Health
33
NCDs
31
Refugee
29
Ebola
29
Global Health Education
23
Conflict
22
Disability
20
Health Financing Toolbox
12
Specific Hazards
10
Natural Hazards
10
Zika
10
Cholera
7
Polio
7
Social Ethics
2
Health Financing
1
Abstract: Chagas disease is caused by infection with the protozoan Trypanosoma cruzi, and although over 100 years have passed since the discovery of Chagas disease, it still presents an increasing problem for global public health. A plethora of information concerning the chronic phase of human Chaga...
WHO needs US$2.54 billion to provide life-saving assistance to millions of people around the world facing health emergencies. WHO’s Health Emergency Appeal is a consolidation of WHO’s priorities and financial requirements for 2023 to carry out health interventions in emergency and humanitarian r...
Theodor Bilharz, a German professor of anatomy and chief of surgery at the Kasr El Ani Hospital of Cairo from 1850, first identified an infective organism, Distomum hematobium in 1851, which was renamed Schistosoma haematobium in 1858. It arose from a cestode worm, Hymenoleptis nana, lying in the sm...
A clear understanding of the knowledge, attitudes and practices (KAP) of a particular community is necessary in order to improve control of human African trypanosomiasis (HAT).New screening and diagnostic tools and strategies were introduced into South Sudan, as part of integrated delivery of primar...
Mycetoma is a specific chronic, granulomatous, inflammatory disease. It usually involves the subcutaneous tissue, most probably after traumatic inoculation of the causative organism. It has a prolonged, progressive, and indolent course, and, if untreated, it ultimately leads to destruction of the de...
Report of a global meeting on yaws eradication surveillance, monitoring and evaluation: Geneva, 29–30 January 2018. World Health Organization.
Skin-related neglected tropical diseases, or “skin NTDs”, are historically neglected because active case detection, individual case management, significant resources and intensive effort are required to control, eliminate and eradicate them. Integrated control and management of skin NTDs offers ...
Malgré les progrès récents vers la mise au point d’un traitement hautement efficace et abordable contre le virus de l’hépatite C, beaucoup de personnes infectées par ce virus ne connaissent pas leur statut. L’Organisation mondiale de la Santé (OMS) estime qu’en 2019, 58 millions ...
The Transformation Agenda (TA) ushered in an ambitious reform process intended to transform the World Health Organization (WHO) into an organization that is proactive, results-driven, accountable and which meets stakeholder expectations, towards transforming and improving public health services in t...
The Country Cooperation Strategy is the World Health Organization’s corporate framework developed in response to a country’s needs and priorities. The 2022–2025 CCS is the fourth for WHO in Sierra Leone. It is a medium-term strategic document that defines a broad framework for WHO’s work, at...
Cystic echinococcosis (CE) is a well-known neglected parasitic disease. However, evidence supporting the four current treatment modalities is inadequate, and treatment options remain controversial. The aim of this work is to analyse the available data to answer clinical questions regarding medical t...
Over the 20 years that followed, this unique partnership has invested more than US$53 billion, saving 44 million lives and reducing the combined death rate from the three diseases by more than half in the countries in which the Global Fund invests.
Previous advocacy efforts have achieved tangible goals in terms garnering political commitments
to increase financing for TB—as seen at the 2018 UN High-Level Meeting on TB. The challenge
now is to ensure that these commitments are actually met within a global biomedical research
ecosystem that...
Building on the 2021 Interim guidance, this second version and update, incorporates the lessons and feedback from the hepatitis pilots that successfully demonstrated the feasibility of measuring hepatitis B and C impact targets to demonstrate elimination, whilst highlighting challenges caused by hig...
Cardiovascular diseases, principally ischemic heart disease (IHD), are the most important cause of death and disability in the majority of low- and lower-middle-income countries (LLMICs). In these countries, IHD mortality rates are significantly greater in individuals of a low socioeconomic status (...
Background: Cardiovascular disease (CVD), mainly heart attack and stroke, is the
leading cause of premature mortality in low and middle income countries (LMICs).
Identifying and managing individuals at high risk of CVD is an important strategy to prevent and control CVD, in addition to multisector...
This technical report has been developed within the framework of the WHO Global Initiative for
Childhood Cancer. Its goal is to improve the situation of children and adolescents with cancer worldwide,
giving them the best chances of survival, living a full life and, above all, enjoying quality of ...
Buruli ulcer (BU) is a bacterial skin infection that is caused by Mycobacterium ulcerans and mainly affects people who reside in the rural areas of Africa and in suburban and beach resort communities in Australia.
Non-communicable diseases (NCDs) are of increasing concern for society and national governments, as well as globally due to their high mortality rate. The main risk factors of NCDs can be classified into the categories of self-management, genetic factors, environmental factors, factors of medical co...
As the Americas undergo profound demographic change and there are more persons aged 65 years or older than children younger than 5 years, it is crucial to recognize that national immunization programs must be redesigned to ensure comprehensive protection for individuals across the lifespan. By adopt...
